Inbrief

Biting back... Swiss pharma giant Novartis is backing a new campaign in its long-term commitment to fighting malaria.

The Power of One campaign (www.Po1.org) aims to address the treatment gap – through direct donations and existing government commitments – in view of the 300m additional treatments estimated to be needed to treat malaria patients across Africa between now and the end of 2015.

Novartis is supporting the campaign financially as well as donating up to three million Coartem Dispersible treatments to match antimalarials funded by the public.